22-Jul-16 In 2012, around 500 mn people in China had an uncorrected visual defect. 450 mn of those had myopia. That’s about a third of the population. And, barring policy interventions, around 700 mn people will have myopia by 2020 - half the population. Global Growth Markets estimates about 2.4 mn people had vision correction surgery in China in 2015, mainly LASIK. [image: Reuters / Damir Sagolj]

29-Jul-16 Allergan Optive Fusion eye drops have shown rapid and continued improvement in dry eye in a study presented at the 2016 Asia Pacific Academy of Ophthalmology Congress in China. Allergan’s Ophthalmology director, Damon Cooke, said: “Dry eye disease is impacting increasing numbers of people as we spend more time looking at screens and living in air conditioned environments.” [image: Allergen Optive Fusion]

28-May-16 Public health strategies are needed in Singapore to increase uptake of presbyopic correction in younger individuals, males and those of Malay and Indian ethnicities. Non-correction is associated with reduced ability to perform individual near and distance vision-specific tasks. [image: Eye Surgeon Asia]

12-Apr-16 Emerging markets focused bank Standard Chartered has launched five eye care projects costing USD1.6 mn to bring in innovation and strengthen the delivery of eye-care to India by 2019. In India, around 15 million people are thought to be blind, with cataract the most avoidable blindness (63%), followed by refractive error (20%) and glaucoma (5.8%). Yet 80% of blindness is avoidable with the right treatment. [image: Standard Chartered Bank]

21-Mar-16 Johnson & Johnson has seen the profitability of its consumer and medical device sectors flag in recent years, prompting activist investor Artisan to put pressure on the firm. The company’s executives recently shared their vision for growing its medical device business with a six-pronged plan that includes boosting its consumer medical devices business and expanding into emerging markets. [image: Johnson & Johnson]